Free Trial

This company recently went public with an IPO on Friday, October 30th 2026. They issued 10,555,555 shares at $15.00 - $17.00 per share. We will continue to update data for BBTX as it becomes available.

Bambusa Therapeutics (BBTX) Insider Trading & Ownership

$16.00 +1.01 (+6.74%)
As of 04:00 PM Eastern

Bambusa Therapeutics (NASDAQ:BBTX) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$12M
Number Of
Insiders Selling
(Last 12 Months)
0
Get BBTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bambusa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBTX Insider Buying and Selling by Quarter

Bambusa Therapeutics Insider and Congressional Trades History

Transaction Date
0 Results
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/2/2026
Helmut Wolfgang Jeggle
Director
Buy375,000$16.00$6,000,000.00  
11/2/2026
Salvia Investment Gmbh
Major Shareholder
Buy375,000$16.00$6,000,000.00  
(Data available from 1/1/2013 forward)

BBTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bambusa Therapeutics includes Helmut Wolfgang Jeggle, and Salvia Investment Gmbh. Learn more on insiders at BBTX.

The following insiders have purchased BBTX shares in the last 24 months: Helmut Wolfgang Jeggle ($6,000,000.00), and Salvia Investment Gmbh ($6,000,000.00).

Insiders have purchased a total of 750,000 BBTX shares in the last 24 months for a total of $12,000,000.00 bought.



Insider trading data for NASDAQ:BBTX was last updated on 11/2/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported.
From Our Partners